Literature DB >> 19774647

Mapping of inflammatory bowel disease in northern France: spatial variations and relation to affluence.

Christophe Declercq1, Corinne Gower-Rousseau, Gwénola Vernier-Massouille, Julia Salleron, Mamadou Baldé, Gilles Poirier, Eric Lerebours, Jean Louis Dupas, Véronique Merle, Raymond Marti, Alain Duhamel, Antoine Cortot, Jean-Louis Salomez, Jean-Frédéric Colombel.   

Abstract

BACKGROUND: Geographic variations in the incidence of inflammatory bowel disease (IBD) may reflect variations in the distribution of environmental etiologic factors. We assessed spatial variation in the incidence of IBD in northern France and analyzed its association with a deprivation index.
METHODS: All cases of IBD included in the EPIMAD registry between 1990 and 2003 were extracted. The standardized incidence ratio (SIR) was calculated for each canton in the region. The association between incidence and deprivation was assessed using the Townsend deprivation index.
RESULTS: The mean annual incidence rates of Crohn's disease (CD) and ulcerative colitis (UC) were 6.2 x 10(-5) and 3.8 x 10(-5), respectively. The mean cumulative numbers of cases by canton were 18.4 (1-183) for CD and 11.3 (0-148) for UC. For both CD and UC, mapping depicted spatial heterogeneity in the SIR with spatial autocorrelation. A high relative risk (RR) of CD was observed in mainly rural and periurban cantons of the region. For UC, a high RR was found in cantons of the south and the center of Pas-de-Calais. No significant correlation was observed between spatial variations in IBD and deprivation.
CONCLUSIONS: The incidence of IBD is associated with spatial heterogeneity in northern France. The noteworthy predominance of CD in agricultural areas warrants further investigations.

Entities:  

Mesh:

Year:  2010        PMID: 19774647     DOI: 10.1002/ibd.21111

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  8 in total

Review 1.  The epidemiology and risk factors of inflammatory bowel disease.

Authors:  Yulan Ye; Zhi Pang; Weichang Chen; Songwen Ju; Chunli Zhou
Journal:  Int J Clin Exp Med       Date:  2015-12-15

2.  Environmental risk factors for inflammatory bowel disease.

Authors:  Natalie A Molodecky; Gilaad G Kaplan
Journal:  Gastroenterol Hepatol (N Y)       Date:  2010-05

3.  Geographical variation of Crohn's disease residual incidence in the Province of Quebec, Canada.

Authors:  Pascal Michel; Laurie St-Onge; Anne-Marie Lowe; Michel Bigras-Poulin; Paul Brassard
Journal:  Int J Health Geogr       Date:  2010-05-12       Impact factor: 3.918

4.  Perinatal and early life risk factors for inflammatory bowel disease.

Authors:  Stephen E Roberts; Clare J Wotton; John G Williams; Myfanwy Griffith; Michael J Goldacre
Journal:  World J Gastroenterol       Date:  2011-02-14       Impact factor: 5.742

Review 5.  Environmental risk factors for inflammatory bowel diseases: Evidence based literature review.

Authors:  Ayokunle T Abegunde; Bashir H Muhammad; Owais Bhatti; Tauseef Ali
Journal:  World J Gastroenterol       Date:  2016-07-21       Impact factor: 5.742

6.  A generic method for improving the spatial interoperability of medical and ecological databases.

Authors:  A Ghenassia; J B Beuscart; G Ficheur; F Occelli; E Babykina; E Chazard; M Genin
Journal:  Int J Health Geogr       Date:  2017-10-03       Impact factor: 3.918

7.  Mesenteric fat as a source of C reactive protein and as a target for bacterial translocation in Crohn's disease.

Authors:  Laurent Peyrin-Biroulet; Florent Gonzalez; Laurent Dubuquoy; Christel Rousseaux; Caroline Dubuquoy; Cécilia Decourcelle; Alain Saudemont; Mickael Tachon; Elodie Béclin; Marie-Françoise Odou; Christel Neut; Jean-Frédéric Colombel; Pierre Desreumaux
Journal:  Gut       Date:  2011-09-21       Impact factor: 23.059

8.  Geographic mapping of Crohn's disease and its relation to affluence in jiangsu province, an eastern coastal province of china.

Authors:  Dong Hu; Jianan Ren; Gefei Wang; Guosheng Gu; Song Liu; Xiuwen Wu; Jun Chen; Huajian Ren; Zhiwu Hong; Jieshou Li
Journal:  Gastroenterol Res Pract       Date:  2014-04-15       Impact factor: 2.260

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.